Selank

Selank is a synthetic heptapeptide analog of tuftsin developed in Russia as an anxiolytic and nootropic. Shows both immunomodulatory and anxiolytic properties without sedation or dependence in research studies.

At a Glance

Summary: Modulates GABA-A receptors and enhances enkephalin activity to reduce anxiety, while regulating cytokines for immunomodulatory effects. Mechanisms (reported/proposed across domains): Neuro / anxiety • Enhances GABAergic neurotransmission, producing anxiolytic effects comparable to benzodiazepines without sedation or dependence. • Inhibits enkephalinase enzymes, increasing endogenous...

Safety Profile

Approved in Russia - Not FDA Approved

Research Dosing

Dose: 200–400 mcg · Route: Intranasal · Subcutaneous (SC) · Frequency: 2–3× daily (intranasal) · Duration: 2–4 weeks

Categories

  • Research Only
  • Nootropic
  • Anxiolytic
  • Immune Support
  • Stress Relief
  • GABA Modulation
  • Mood Support
  • Cognitive Function
  • Russia Approved
  • Clinical Data Available

Related Peptides

The Leading Community for Trusted Peptide Research & Insights

Research summaries, dosing protocols, and community reports for peptides. Built on clinical data and real-world experiences.